Hugues Michelon1, Julie Marcel2, Mathieu Coudert3, Kim Juillard4, Laurence Pochat4, Christine Fernandez5, Marc Verny6, Marie Antignac5. 1. Service de pharmacie, Hôpital Raymond Poincaré, Hôpitaux universitaires Paris Ile de France Ouest, Assistance Publique - Hôpitaux de Paris, France. 2. Service de pharmacie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, France. 3. Unité de recherche clinique, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, France. 4. Échelon local du Service médical de Paris (Assurance Maladie), Paris, France. 5. Service de pharmacie, Hôpital Saint-Antoine, Hôpitaux universitaires Est Parisien, Assistance Publique - Hôpitaux de Paris, France. 6. Centre de gériatrie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, Université Pierre et Marie Curie - Paris 6, France.
Abstract
OBJECTIVES: To assess the impact of physician awareness to promote the prescription and the dispensing of generic drugs at hospital discharge. METHODS: The study consisted in a Before/After Study design including the analysis of medical prescriptions at hospital discharge, after a pharmaceutical intervention to physicians in a geriatric ward. Each drug was classified according to its terms of prescribing (International Nonproprietary Name (INN), Generic or Trade Name). The primary endpoint defined is the rate of medication prescribed by INN or generic. Statistical analysis was performed on all medicines and according to the prescribers' status (junior/senior). RESULTS: Three hundred and fifty one drugs were prescribed in the group "before intervention" versus 301 in the group "after". The average number of drugs prescribed per patient was similar between the two groups (9.5 drugs/patient). A generic prescription has been improved by 5% between the two periods (19.7% "before" vs 24.3% "after", p=0.27). Analysis on prescriber status indicates that the pharmaceutical intervention had a significant impact on junior physicians, which resulted in improved prescribing of drug (INN or generic) from 17.6% to 31.4% between the two periods (p=0.006). CONCLUSION: The pharmaceutical intervention to physicians has led to an improvement of drug prescription (INN or generic) at hospital discharge. This awareness has affected mainly junior prescribers hence the need to extend this type of intervention to all prescribers of our establishment.
OBJECTIVES: To assess the impact of physician awareness to promote the prescription and the dispensing of generic drugs at hospital discharge. METHODS: The study consisted in a Before/After Study design including the analysis of medical prescriptions at hospital discharge, after a pharmaceutical intervention to physicians in a geriatric ward. Each drug was classified according to its terms of prescribing (International Nonproprietary Name (INN), Generic or Trade Name). The primary endpoint defined is the rate of medication prescribed by INN or generic. Statistical analysis was performed on all medicines and according to the prescribers' status (junior/senior). RESULTS: Three hundred and fifty one drugs were prescribed in the group "before intervention" versus 301 in the group "after". The average number of drugs prescribed per patient was similar between the two groups (9.5 drugs/patient). A generic prescription has been improved by 5% between the two periods (19.7% "before" vs 24.3% "after", p=0.27). Analysis on prescriber status indicates that the pharmaceutical intervention had a significant impact on junior physicians, which resulted in improved prescribing of drug (INN or generic) from 17.6% to 31.4% between the two periods (p=0.006). CONCLUSION: The pharmaceutical intervention to physicians has led to an improvement of drug prescription (INN or generic) at hospital discharge. This awareness has affected mainly junior prescribers hence the need to extend this type of intervention to all prescribers of our establishment.